Kronox Lab Sciences Limited Earnings Summary — Q1 FY2027
Kronox Lab Sciences Reports Robust 15% YoY Revenue Growth and Sustained High Margins in Q1 FY2027
Quarterly Business Intelligence
AI Quarterly Scorecard™
Computed deterministically from the last 10 reported quarters.
Quarterly Business Momentum
- Revenue has increased for 3 consecutive quarters.
- Revenue of ₹28 Cr is 16.9% higher year-on-year.
- Revenue has compounded at 11.6% annualised over the last 10 quarters.
- Revenue is at its highest level in 10 quarters.
- Net profit of ₹7 Cr is 16.2% above the same quarter last year.
- Profit growth is trailing revenue growth this quarter.
- Net profit has compounded at 10.1% annualised across the period.
- Operating margin stands at 31.7% in Q1 FY2027.
- Operating margin compressed by 114 bps year-on-year.
- Over the last two years operating margin has contracted by 92 bps.
- PBT margin is 34.5%.
- Expenses grew 18.9% against revenue growth of 16.9%.
- Operating profit of ₹9 Cr is 12.8% higher year-on-year.
- Operating leverage has been under pressure recently.
- 4 of the last 6 measured quarters delivered year-on-year revenue growth.
- Overall quarterly business momentum scores 68/100 (Healthy) on the latest 10 quarters.
- Business momentum remains positive heading into the next quarter.
Quarterly Financials
Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %
| Metric | Trend | Latest Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Stable | 28 | 26 | 25 | 26 | 24 | 26 | 24 | 25 | 25 | 22 |
| Expenses | Improving | 19 | 17 | 17 | 17 | 16 | 18 | 16 | 16 | 17 | 14 |
| Operating Profit | Stable | 9 | 10 | 8 | 9 | 8 | 8 | 8 | 9 | 8 | 8 |
| Operating Margin | Stable | 31.7% | 36.4% | 31.8% | 33.9% | 32.8% | 29.7% | 34.8% | 35.4% | 32.6% | 35.4% |
| Other Income | Volatile | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 |
| Interest | Declining | 0 | 0 | 0 | 0 | — | — | — | — | — | — |
| Depreciation | Improving | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | Stable | 10 | 11 | 9 | 9 | 8 | 8 | 9 | 9 | 8 | 8 |
| Tax | Stable | 3 | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 3 |
| Net Profit | Stable | 7 | 8 | 7 | 7 | 6 | 6 | 7 | 6 | 6 | 6 |
| Net Margin | Stable | 25.7% | 30.6% | 26.1% | 26.2% | 25.9% | 24.2% | 27.2% | 26.0% | 24.4% | 26.5% |
Key Takeaways
- Revenue from operations grew by 15% YoY to ₹2,838.5 lakhs, driven by steady demand for high-purity speciality fine chemicals.
- The company maintained strong profitability with a Net Profit of ₹730.3 lakhs, a significant improvement from ₹627.3 lakhs in the same quarter last year.
- Sequentially, performance showed a slight dip in net profit (-8.74%) compared to Q4 FY2026, despite higher revenue, likely due to increased raw material costs.
- Operational efficiency remains a core strength, with the company operating in a single reporting segment of high-purity speciality fine chemicals.
- The Board has set the 17th Annual General Meeting for September 16, 2026, with a book closure for determining final dividend eligibility.
- Kronox remains a lean organization with minimal finance costs (₹3.3 lakhs) and a robust balance sheet structure.
Management Guidance
Management continues to focus on its niche segment of 185+ high-purity products to avoid the volatility of commodity chemicals. Growth strategy prioritizes internal accruals and zero debt for future expansion.
Sentiment Shift
Stable
Year-over-year performance remains strong with healthy margin retention, although quarter-on-quarter profit contraction suggests short-term cost pressures.
Outlook
The company is well-positioned to leverage its debt-free status and high return ratios. Future growth will depend on scaling its speciality chemicals portfolio and navigating the potential governance shift following recent open offer activities.
From the Annual Report (Key Quotes)
“The Company is having only one reportable segment... i.e. manufacturing of High purity Speciality Fine chemical.”
“Register of Members and Share Transfer Books [will close] for the purpose of 17th Annual General Meeting and determining entitlement of the members of the final dividend.”
Official Quarterly Documents
Ask AI about this quarter
This summary is AI-generated from Kronox Lab Sciences Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.